# TissUse

German company TissUse developed the proprietary HUMIMIC technology, integrating built-in pneumatic micropumps for long-term (up to 28 days) 4-organ systemic co-culturing.

Source: https://en.bioecon.ru/companies/tissuse/
Updated: 2026-07-02

- Country: Germany

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Certification | ISO 9001:2015 certified Quality Management System | https://biomed21.org/wp-content/uploads/2021/03/TissUse_Uwe-Marx-Korea-2021.pdf, https://www.tissuse.com/en/technology/, https://www.tissuse.com/files/upload/technology/Zertifikat%20RZ%20912191000_2%20eng.PDF |
| Headquarters | Berlin, Germany | https://www.northdata.com/TissUse%20GmbH,%20Berlin/Amtsgericht%20Charlottenburg%20(Berlin)%20HRB%20173785%20B |
| Production site | Berlin (Oudenarder Str. 16) and Spreenhagen, Germany | https://biomed21.org/wp-content/uploads/2021/03/TissUse_Uwe-Marx-Korea-2021.pdf, https://www.northdata.com/TissUse%20GmbH,%20Berlin/Amtsgericht%20Charlottenburg%20(Berlin)%20HRB%20173785%20B, https://www.tissuse.com/en/news/media/?file=files%2Fupload%2Fposter%2FMulti-Organ-Chip+Developments.pdf |
| Capacity | In-house manufacturing of HUMIMIC platforms (Starter and AutoLab) and rapid prototyping for custom chip designs | https://biomed21.org/wp-content/uploads/2021/03/TissUse_Uwe-Marx-Korea-2021.pdf, https://www.tissuse.com/en/news/media/?file=files%2Fupload%2Fposter%2FMulti-Organ-Chip+Developments.pdf, https://www.tissuse.com/en/services/ |
| Regulatory approval | No direct regulatory product approvals; active in qualifying assays with regulatory frameworks (e.g., FDA) for nonclinical testing [medium confidence] | https://biomed21.org/wp-content/uploads/2021/03/TissUse_Uwe-Marx-Korea-2021.pdf |

Independent sources: biomed21.org, northdata.com

## Technologies

- [Organoids & organ-on-chip](https://en.bioecon.ru/technology/organoids-organ-on-chip/)